Hit-to-lead development of CaMKII-HDAC4 inhibitory compounds to treat heart failure
| Institution | Georg-August-Universität Göttingen - Universitätsmedizin |
|---|---|
| Project leader | Wolfram-Hubertus Zimmermann |
| Site | Göttingen |
| Project type | Translational Research Project |
| Funding | € 42.744,99 |
| Begin | 01.11.2019 |
| End | 28.02.2021 |
| Partnerprojekte |
Förderkennzeichen
81X2300199
Projektnummer
1132